Navigation Links
UCB Sponsors Data Presentations on Epilepsy and Vimpat® (lacosamide) C-V at the 64th Annual Meeting of the American Academy of Neurology
Date:4/18/2012

y 50 million people worldwide and 3 million people in the U.S. Anyone can develop epilepsy; it occurs across all ages, races, and genders.  Uncontrolled seizures and medication side effects pose challenges to independent living, learning, and employment, so the goal of epilepsy treatment is seizure freedom with minimal side effects.  In the U.S., more than 1 million patients continue to have seizures despite initial therapy, and more than 800,000 continue to have seizures despite treatment with two or more therapies.  [1],[2]

About Vimpat®

Vimpat® tablets and injection were launched in the U.S. in May 2009 as an add-on therapy for the treatment of partial-onset seizures in people with epilepsy who are aged 17 years and older.  Vimpat® injection is a short-term replacement when oral administration is not feasible in these patients.  Vimpat® oral solution was launched in June 2010.  The availability of the oral tablets, oral solution, and intravenous (IV) injection allows for consistent treatment in a hospital setting. 

In the European Union, Vimpat® (film-coated tablets, syrup, and solution for infusion) is approved as adjunctive therapy for the treatment of partial-onset seizures with or without secondary generalization in patients with epilepsy aged 16 years and older. Vimpat® solution for infusion may be used when oral administration is temporarily not feasible.

The maximum approved daily dose for Vimpat® in the European Union and the U.S. is 400 mg/day.

Important safety information about Vimpat® in the U.S.

Warnings and Precautions

Antiepileptic drugs (AEDs) increase the risk of suicidal behavior and ideation. Patients taking Vimpat® should be monitored for the emergence or worsening of depression, suicidal thoughts or behavior, and/or any unusual changes in mood or behavior
'/>"/>

SOURCE UCB
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Sunpeaks Ventures Inks Sponsorship and Marketing Agreement with Major Sports Team, Clotamin To Be Sold at Walgreens Locations Throughout Oregon and Southern Washington
2. Millennium Laboratories Sponsors Physician Education on Safe Opioid Prescribing at American Academy of Pain Medicine Annual Meeting
3. Celling Biosciences Sponsors 7th Annual Stem Cell Summit
4. Parata Systems Announces Presenting Sponsorship of 2012 Independent Pharmacy Business Growth Conference
5. goBalto Sponsors Tufts CSDD Study to Benchmark the Clinical Trial Initiation Process
6. Zimmer Sponsors Winter National Senior Games
7. Boston Scientific Sponsors New Patient Portal Dedicated to Pelvic Floor Disorders
8. Emergency Nurses Association Announces Corporate Sponsors for Annual Conference
9. SuccessEHS Sponsors California Primary Care Association
10. Johnson & Johnson Announces Global Sponsorship of the 2014 FIFA World Cup Brazil™
11. Octapharma USA Sponsors International Advisory Board for Evaluating Treatment of Patients with von Willebrand Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Aug. 28, 2014  Rigrodsky & Long, P.A.: , ... Inc. (NYSE: LCI )? , Did you purchase ... and July 16, 2014, inclusive? , Did you lose ... Do you want to discuss your rights? ... States Attorney, Timothy J. MacFall , announces that a complaint ...
(Date:8/28/2014)... NEW YORK , Aug. 28, 2014 ... market research report is available in its ... Market Forecast 2014-2024 ... Needle-free delivery – discover technological and commercial ... the needle-free delivery market? Visiongain,s brand new ...
(Date:8/28/2014)... YORK , Aug. 28, 2014 ... is available in its catalogue: North ... http://www.reportlinker.com/p02343464/North-America-Laparoscopes-Market-Outlook-to-2020.html North America ... GlobalData,s new report, "North America Laparoscopes Market Outlook ... North America Laparoscopes market. The report provides value, ...
Breaking Medicine Technology:Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lannett Company, Inc. 2Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lannett Company, Inc. 3Needle-Free Delivery: Technology and Market Forecast 2014-2024 2Needle-Free Delivery: Technology and Market Forecast 2014-2024 3Needle-Free Delivery: Technology and Market Forecast 2014-2024 4Needle-Free Delivery: Technology and Market Forecast 2014-2024 5Needle-Free Delivery: Technology and Market Forecast 2014-2024 6Needle-Free Delivery: Technology and Market Forecast 2014-2024 7Needle-Free Delivery: Technology and Market Forecast 2014-2024 8Needle-Free Delivery: Technology and Market Forecast 2014-2024 9Needle-Free Delivery: Technology and Market Forecast 2014-2024 10Needle-Free Delivery: Technology and Market Forecast 2014-2024 11Needle-Free Delivery: Technology and Market Forecast 2014-2024 12Needle-Free Delivery: Technology and Market Forecast 2014-2024 13Needle-Free Delivery: Technology and Market Forecast 2014-2024 14Needle-Free Delivery: Technology and Market Forecast 2014-2024 15Needle-Free Delivery: Technology and Market Forecast 2014-2024 16Needle-Free Delivery: Technology and Market Forecast 2014-2024 17Needle-Free Delivery: Technology and Market Forecast 2014-2024 18North America Laparoscopes Market Outlook to 2020 2North America Laparoscopes Market Outlook to 2020 3North America Laparoscopes Market Outlook to 2020 4North America Laparoscopes Market Outlook to 2020 5North America Laparoscopes Market Outlook to 2020 6North America Laparoscopes Market Outlook to 2020 7North America Laparoscopes Market Outlook to 2020 8North America Laparoscopes Market Outlook to 2020 9North America Laparoscopes Market Outlook to 2020 10North America Laparoscopes Market Outlook to 2020 11
... 2010 According to Millennium Research Group (MRG), the ... intensify in the $740 million minimally invasive spinal fusion ... "In 2010, the US minimally invasive spinal ... and Medtronic Spinal & Biologics," says Deanna Vankessel, Senior ...
... Life Spine announced today that the company has ... System, which is intended for attachment to the spinous ... with bone graft. The U.S. Food and Drug Administration ... last month. The unique implant core ...
Cached Medicine Technology:Competition To Increase in the $740 Million Minimally Invasive Spinal Fusion Market 2Competition To Increase in the $740 Million Minimally Invasive Spinal Fusion Market 3
(Date:8/29/2014)... Pursuing its deepest desires to help build ... stunning new design that promises to redefine the global ... surrogacy platform has witnessed a 42 percent increase in ... month, the FindSurrogateMother.com community is formed by hopeful parents ... — the precious gift of life. , Whether intended ...
(Date:8/29/2014)... News) -- If you have bunions, taking care of them ... expert says. A bunion is a bump that forms ... tissue moves out of place and extends beyond the normal ... pain and may require surgery to correct, said Brent Rosenthal, ... Freehold, N.J. To prevent bunions, avoid wearing shoes with ...
(Date:8/29/2014)... NEW YORK August 29, 2014 - Despite US ... obesity, there are many barriers, several of which may ... study by researchers at NYU Langone Medical Center published ... General Internal Medicine ( JGIM ). , David ... Department of Internal Medicine at NYU Langone, and colleagues ...
(Date:8/29/2014)... AURORA, Colo. (Sept. 2, 2014) A team of ... has reported the breakthrough discovery of a process to ... patients. These findings could have implications that extend beyond ... and autoimmune diseases., In an article published ... the Charles C. Gates Center for Regenerative Medicine and ...
(Date:8/29/2014)... 29, 2014 Today, NBC’s “The ... who profiled a handful of safe, back to ... Research. This year, many schools will include earphones ... innovator of hearing wellness solutions, offers the best ... Earphones, offered in yellow, pink and black, sound ...
Breaking Medicine News(10 mins):Health News:FindSurrogateMother.com Set to Unveil Stunning New Design as Member Sign-ups Increase by 42% since January 2Health News:FindSurrogateMother.com Set to Unveil Stunning New Design as Member Sign-ups Increase by 42% since January 3Health News:Take Steps to Control Bunions 2Health News:Options for weight loss your primary care doctor might not know about 2Health News:CU scientists' discovery could lead to new cancer treatment 2Health News:The Today Show Features ETY•Kids® Safe-Listening Earphones by Etymotic 2
... addictions to stimulants tend to choose instant gratification or a ... the future reward is greater. Reduced value of a ... challenge for treatment of addiction. A new study in the ... appears to present a strategy for increasing the value of ...
... Jan. 27 (HealthDay News) -- About one-fourth of all black ... their risk for coronary artery disease, new research reveals. ... linked to a higher risk for heart disease ... that in black men and women who carry this single ...
... Patients with obstructive sleep apnea who undergo surgery to improve ... less drowsy during the day, according to a new study ... study finds surgery greatly reduces daytime sleepiness a common ... is partially or completely blocked during sleep when compared ...
... 27, 2011 Screening patients in the intensive care ... savings for the whole hospital, according to a study ... February issue of the American Journal of Infection ... Association for Professionals in Infection Control and Epidemiology. ...
... Injury Research and Policy of The Research Institute at ... adolescents 6 to 18 years old and found that ... departments from 1994 through 2007, for an average of ... study period, the annual number of running-related injuries increased ...
... HealthDay Reporter , THURSDAY, Jan. 27 (HealthDay News) ... hot flashes and other menopausal symptoms: Your risk for breast ... from the Fred Hutchinson Cancer Research Center in Seattle report. ... risk, and we also know that menopausal symptoms occur primarily ...
Cached Medicine News:Health News:Memory training explored as strategy for addiction treatment 2Health News:Memory training explored as strategy for addiction treatment 3Health News:Gene Mutation May Protect Blacks From Heart Disease 2Health News:Surgery for obstructive sleep apnea reduces daytime drowsiness 2Health News:Study finds MRSA screening saves hospitals money 2Health News:Study Ties Hot Flashes to Lower Breast Cancer Risk 2Health News:Study Ties Hot Flashes to Lower Breast Cancer Risk 3
ZYMAR™ ophthalmic solution is an anti-infective prescription eye drop that your doctor may instruct you to use if you have an eye infection caused by bacteria. Bacterial conjunctivitis is the e...
... P.M.® lets you sleep on ... in the morning awake with ... ready to take on the ... comfort and protection, this preservative-free ...
Due to its thick formula, REFRESH CELLUVISC Lubricant Eye Drops is ideal for persistent dry eye conditions. REFRESH CELLUVISC provides lasting relief and protection for dry, scratchy eyes....
ALPHAGAN® (brimonidine tartrate ophthalmic solution) 0.2% is indicated for lowering IOP in patients with open-angle galucoma or ocular hypertension....
Medicine Products: